Milestone Scientific Launches New User-Friendly, Multi-Platform Compatible Website
LIVINGSTON, NJ -- (Marketwired) -- 07/28/17 -- Milestone Scientific Inc . (NYSE MKT: MLSS) invites visitors to explore its new website. The website is focused on bringing Milestone's technology to the medical industry and establishing Milestone's platform technology as the standard-of-care in painless and precise drug delivery in the U.S., Europe and around the world. This vision has now been realized with the recent FDA clearance of the CompuFlo® epidural instrument, as well as European marketing clearance of both the epidural and intra-articular instruments.
The website was created with the user experience central to its design, using the latest technology so the site is fully compatible with all browsers and is fully responsive to large monitors and mobile devices alike. Press releases and SEC filings are automatically posted as they occur and stock information data is updated on demand with a 20-minute delay. The new website is easy to navigate and will be continually updated with the latest product information.
About Milestone Scientific Inc.
Milestone Scientific Inc. (MLSS) is a leading medical research and development company that designs and patents innovative injection technology. Milestone's computer-controlled systems make injections precise, efficient, and virtually painless. For more information please visit our website: www.milestonescientific.com.
Safe Harbor Statement
This press release contains forward-looking statements regarding the timing and financial impact of Milestone's ability to implement its business plan, expected revenues and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone's control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and the risk factors detailed from time to time in Milestone's periodic filings with the Securities and Exchange Commission, including without limitation, Milestone's Annual Report for the year ended December 31, 2015. The forward looking statements in this press release are based upon management's reasonable belief as of the date hereof. Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason.
David Waldman or Natalya Rudman
Crescendo Communications, LLC
Source: Milestone Scientific, Inc.
Released July 28, 2017